Suppr超能文献

抗逆转录病毒药物在儿童HIV感染中的耐受性。

Tolerabilities of antiretrovirals in paediatric HIV infection.

作者信息

Lemberg Daniel Avi, Palasanthiran Pamela, Goode Michele, Ziegler John B

机构信息

Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, New South Wales, Australia.

出版信息

Drug Saf. 2002;25(14):973-91. doi: 10.2165/00002018-200225140-00001.

Abstract

Data on the efficacy and tolerability of antiretrovirals in children are limited as, in contrast to adult studies, large paediatric cohort studies are lacking. Thus, data pertaining to adults are often extrapolated to children despite the acknowledgement that children are not little adults. This review summarises information gathered from existing reports and focuses on the tolerabilities of antiretrovirals in children infected with HIV-1. The efficacy of antiretrovirals is not included in the scope of the discussion. Taste of antiretrovirals should be an important factor when considering the tolerability of antiretrovirals in children. However, antiretroviral options are often limited in young children as only some of the antiretrovirals are available as paediatric formulations. All antiretrovirals have been associated with toxicities in children, but in general, they are relatively well tolerated. The gastrointestinal system including hepatic system is most prone to being affected by these drugs. Skin rashes and hypersensitivity reactions are also associated with antiretroviral use, particularly with the non-nucleoside reverse transcriptase inhibitors. Mitochondrial toxicities that lead to impairment of liver function, pancreatic function and lactic acidosis are associated with most of the nucleoside analogues. Haematological toxicity is often a dose limiting adverse effect especially of the nucleoside analogues, in particular zidovudine. The protease inhibitors are associated with gastrointestinal intolerance (diarrhoea) and metabolic derangements that can lead to hypercholesterolaemia and hypertriglyceridaemia, which in turn and can lead to changes in body habitus. The renal system is also affected by several drugs, the most important of which is indinavir, which has been associated with renal stones and damage to the renal tubules. Fortunately, with lower incidence of major toxicity and with the range of drugs now available for paediatric use, toxicities are usually not a barrier to effect antiretroviral therapy in children.

摘要

与成人研究不同,由于缺乏大型儿科队列研究,关于抗逆转录病毒药物在儿童中的疗效和耐受性的数据有限。因此,尽管人们承认儿童并非小成年人,但有关成人的数据常常被外推用于儿童。本综述总结了从现有报告中收集的信息,并着重关注感染HIV-1的儿童对抗逆转录病毒药物的耐受性。抗逆转录病毒药物的疗效不在讨论范围内。在考虑抗逆转录病毒药物在儿童中的耐受性时,药物口味应是一个重要因素。然而,幼儿可用的抗逆转录病毒药物选择往往有限,因为只有部分抗逆转录病毒药物有儿科剂型。所有抗逆转录病毒药物在儿童中都有相关毒性,但总体而言,它们的耐受性相对良好。包括肝脏系统在内的胃肠系统最容易受到这些药物的影响。皮疹和过敏反应也与抗逆转录病毒药物的使用有关,尤其是非核苷类逆转录酶抑制剂。导致肝功能、胰腺功能损害和乳酸性酸中毒的线粒体毒性与大多数核苷类似物有关。血液学毒性往往是剂量限制性不良反应,尤其是核苷类似物,特别是齐多夫定。蛋白酶抑制剂与胃肠道不耐受(腹泻)和代谢紊乱有关,可导致高胆固醇血症和高甘油三酯血症,进而可能导致体型改变。肾脏系统也受到几种药物的影响,其中最重要的是茚地那韦,它与肾结石和肾小管损伤有关。幸运的是,由于主要毒性的发生率较低,且现在有多种儿科可用药物,毒性通常不会成为儿童有效抗逆转录病毒治疗的障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验